Literature DB >> 20385321

Misdiagnosis in Fabry disease.

Cintia L Marchesoni1, Norma Roa, Ana María Pardal, Pablo Neumann, Guillermo Cáceres, Pablo Martínez, Isaac Kisinovsky, Silvia Bianchi, Ana Lía Tarabuso, Ricardo C Reisin.   

Abstract

OBJECTIVE: To evaluate the most frequent diagnostic errors in patients with Fabry disease and the types of specialists most often consulted before diagnosis. STUDY
DESIGN: We evaluated 45 consecutive symptomatic patients with Fabry disease confirmed by enzymatic tests in males and genetic studies in females. We interviewed the patients, their mothers, or both regarding symptoms, age at onset, medical consultations, and recommended treatments.
RESULTS: Neuropathic pain was the most frequent initial complaint, and rheumatic fever was the most common diagnosis. Seven patients were treated with penicillin for many years. Ten patients sought medical consultation because of abdominal pain and were diagnosed with food intoxication or nonspecific pain. Six patients sought consultation because of anhidrosis, considered of unclear cause, and angiokeratomas diagnosed as petechiae. Internists and pediatricians were the most frequently consulted specialists. The correct diagnosis was obtained after a mean of 19.7 years.
CONCLUSIONS: Pediatricians as well as internists commonly misdiagnose Fabry disease. Neuropathic pain, hypohidrosis, and recurrent abdominal pain in childhood or adolescence should include Fabry disease in the differential diagnosis to facilitate earlier diagnosis and treatment of these patients.

Entities:  

Mesh:

Year:  2010        PMID: 20385321     DOI: 10.1016/j.jpeds.2010.02.012

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

Review 1.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  Lessons from two cases: is Fabry disease the correct diagnosis?

Authors:  Ertugrul Kiykim; Cigdem Ayse Aktuglu Zeybek; Tanyel Zubarioglu; Ahmet Aydin
Journal:  BMJ Case Rep       Date:  2015-05-12

3.  Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin.

Authors:  Raffaele Manna; Roberto Cauda; Sandro Feriozzi; Giovanni Gambaro; Antonio Gasbarrini; Didier Lacombe; Avi Livneh; Alberto Martini; Huri Ozdogan; Antonio Pisani; Eleonora Riccio; Elena Verrecchia; Lorenzo Dagna
Journal:  Intern Emerg Med       Date:  2017-07-19       Impact factor: 3.397

4.  FabryScan: a screening tool for early detection of Fabry disease.

Authors:  Kathrin Arning; Dennis Naleschinski; Rainer Maag; Marieke Biegstraaten; Peter Kropp; Jürgen Lorenzen; Carla E M Hollak; Ivo N van Schaik; Pontus Harten; Rainald A Zeuner; Andreas Binder; Ralf Baron
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

5.  Early clinical signs in lysosomal diseases.

Authors:  Camelia Alkhzouz; Diana Miclea; Simona Bucerzan; Cecilia Lazea; Ioana Nascu; Paula Grigorescu Sido
Journal:  Med Pharm Rep       Date:  2021-08-10

6.  Early diagnosis of fabry disease in a patient with toe tip pain.

Authors:  Ki Bum Park; Kyung Ream Han; Jae Woo Lee; Seung Ho Kim; Do Wan Kim; Chan Kim; Jung Min Ko
Journal:  Korean J Pain       Date:  2010-08-26

Review 7.  Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis.

Authors:  Claire Zar-Kessler; Amel Karaa; Katherine Bustin Sims; Virginia Clarke; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2016-04-15       Impact factor: 4.409

Review 8.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

9.  High variability of Fabry disease manifestations in an extended Italian family.

Authors:  Giuseppe Cammarata; Pasquale Fatuzzo; Margherita Stefania Rodolico; Paolo Colomba; Luigi Sicurella; Francesco Iemolo; Carmela Zizzo; Riccardo Alessandro; Caterina Bartolotta; Giovanni Duro; Ines Monte
Journal:  Biomed Res Int       Date:  2015-04-22       Impact factor: 3.411

10.  Significant improvement in Fabry disease podocytopathy after 3 years of treatment with agalsidase beta.

Authors:  Shuichi Ito; Masao Ogura; Koichi Kamei; Kentaro Matsuoka; David G Warnock
Journal:  Pediatr Nephrol       Date:  2016-04-29       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.